PatentLawPortal

'Biotech Patents' Category

• CAFC: Enablement for 102 Not the Same as Enablement Under 112

  The Court of Appeals for the Federal Circuit held that the effectiveness of the prior art is not relevant but rather whether it describes the claimhttp://www.patentbaristas.com/archives/000…Technorati Tags: patent, Federal Circuit

  November 29th, 2006

• Supreme Court Hears Arguments in KSR

  The Supreme Court today heard oral arguments in the case of KSR International v. Teleflex. Already a group named the

  November 28th, 2006

• Court: When is a Pentetate Equivalent to an Edetate?

  The doctrine of equivalents was upheld for AstraZenaca’s patent on Propofol, used to induce and maintain general anaesthesia and sedation in patienhttp://www.patentbaristas.com/archives/000…Technorati Tags: patent

  November 22nd, 2006

• D.C. Circuit: Merck Can’t Pull the Rug Out From Under Para IV Listers

  Ranbaxy and Teva won a victory in the U.S. Court of Appeals for the D.C. Circuit that preserved their 180-day exclusivity when patents are delistedhttp://www.patentbaristas.com/archives/000…Technorati Tags: patent, patents

  November 17th, 2006

• Biotech Drugs: How to Spend $1.2 Billion

  If you think things are getting more expensive, it may not be your imagination. The Tufts Center for the http://www.patentbaristas.com/archives/000…Technorati Tags: patent

  November 15th, 2006

• Poll: Your Top Legal Blog

  Robert Ambrogi’s LawSites is running a

  November 4th, 2006

• Friday Editorial: What Do the Elections Mean to Pharma?

  Many are asking what will happen if Democrats take control of the House and Senate. While I’m not interested in taking sides, I think that the isshttp://www.patentbaristas.com/archives/000…Technorati Tags: patent

  November 3rd, 2006

• Invitrogen Gets Triple Damages in E. coli Competent Cell Case

  After a jury determined that Stratagene infringed on Invitrogen’shttp://www.patentbaristas.com/archives/000…Technorati Tags: patent

  November 3rd, 2006

• Eisai Prevails: Motion For Summary Judgement

  Eisai Co., Ltd. (Headquarters: Tokyo, President and CEO: Haruo Naito) and Eisai Inc. (Headquarters: New Jersey, Chairman and CEO: Hajime Shimizu) thttp://www.patentbaristas.com/archives/000…Technorati Tags: patent

  October 31st, 2006

• Imitrex - Authorized Generic Steps In

  Authorized generics — brand pharmaceutical products masquerading as generics — are an increasingly common brand tactic aimed at discouraging genehttp://www.patentbaristas.com/archives/000…Technorati Tags: patent

  October 30th, 2006